220 related articles for article (PubMed ID: 32762779)
1. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months.
Wenneberg C; Glenthøj BY; Glenthøj LB; Fagerlund B; Krakauer K; Kristensen TD; Hjorthøj C; Edden RAE; Broberg BV; Bojesen KB; Rostrup E; Nordentoft M
Eur Psychiatry; 2020 Aug; 63(1):e83. PubMed ID: 32762779
[TBL] [Abstract][Full Text] [Related]
2. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition.
Wenneberg C; Nordentoft M; Rostrup E; Glenthøj LB; Bojesen KB; Fagerlund B; Hjorthøj C; Krakauer K; Kristensen TD; Schwartz C; Edden RAE; Broberg BV; Glenthøj BY
Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Jun; 5(6):569-579. PubMed ID: 32008981
[TBL] [Abstract][Full Text] [Related]
3. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
[TBL] [Abstract][Full Text] [Related]
5. Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of
Wenneberg C; Glenthøj BY; Hjorthøj C; Buchardt Zingenberg FJ; Glenthøj LB; Rostrup E; Broberg BV; Nordentoft M
Schizophr Res; 2020 Jan; 215():38-48. PubMed ID: 31784336
[TBL] [Abstract][Full Text] [Related]
6. Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis.
Egerton A; Stone JM; Chaddock CA; Barker GJ; Bonoldi I; Howard RM; Merritt K; Allen P; Howes OD; Murray RM; McLean MA; Lythgoe DJ; O'Gorman RL; McGuire PK
Neuropsychopharmacology; 2014 Nov; 39(12):2891-9. PubMed ID: 24917199
[TBL] [Abstract][Full Text] [Related]
7. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Reid MA; Salibi N; White DM; Gawne TJ; Denney TS; Lahti AC
Schizophr Bull; 2019 Jan; 45(1):180-189. PubMed ID: 29385594
[TBL] [Abstract][Full Text] [Related]
8. Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation.
Allen P; Chaddock CA; Egerton A; Howes OD; Barker G; Bonoldi I; Fusar-Poli P; Murray R; McGuire P
Schizophr Bull; 2015 Mar; 41(2):429-39. PubMed ID: 25123110
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.
Vingerhoets C; Tse DH; van Oudenaren M; Hernaus D; van Duin E; Zinkstok J; Ramaekers JG; Jansen JF; McAlonan G; van Amelsvoort T
J Psychopharmacol; 2020 Aug; 34(8):856-863. PubMed ID: 32448020
[TBL] [Abstract][Full Text] [Related]
10. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality.
Meyerhoff DJ; Mon A; Metzler T; Neylan TC
Sleep; 2014 May; 37(5):893-900. PubMed ID: 24790267
[TBL] [Abstract][Full Text] [Related]
11. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.
Bojesen KB; Broberg BV; Fagerlund B; Jessen K; Thomas MB; Sigvard A; Tangmose K; Nielsen MØ; Andersen GS; Larsson HBW; Edden RAE; Rostrup E; Glenthøj BY
Biol Psychiatry; 2021 Feb; 89(3):278-287. PubMed ID: 32928500
[TBL] [Abstract][Full Text] [Related]
12. Restless legs syndrome and central nervous system gamma-aminobutyric acid: preliminary associations with periodic limb movements in sleep and restless leg syndrome symptom severity.
Winkelman JW; Schoerning L; Platt S; Jensen JE
Sleep Med; 2014 Oct; 15(10):1225-30. PubMed ID: 25129262
[TBL] [Abstract][Full Text] [Related]
13. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram.
Brennan BP; Admon R; Perriello C; LaFlamme EM; Athey AJ; Pizzagalli DA; Hudson JI; Pope HG; Jensen JE
Psychiatry Res Neuroimaging; 2017 Nov; 269():9-16. PubMed ID: 28892734
[TBL] [Abstract][Full Text] [Related]
14. Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
Wang AM; Pradhan S; Coughlin JM; Trivedi A; DuBois SL; Crawford JL; Sedlak TW; Nucifora FC; Nestadt G; Nucifora LG; Schretlen DJ; Sawa A; Barker PB
JAMA Psychiatry; 2019 Mar; 76(3):314-323. PubMed ID: 30624573
[TBL] [Abstract][Full Text] [Related]
15. A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T.
Licata SC; Jensen JE; Penetar DM; Prescot AP; Lukas SE; Renshaw PF
Psychopharmacology (Berl); 2009 May; 203(4):819-29. PubMed ID: 19125238
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic metabolite correlations with neuropsychological tests in first episode schizophrenia.
Dempster K; Norman R; Théberge J; Densmore M; Schaefer B; Williamson P
Psychiatry Res; 2015 Aug; 233(2):180-5. PubMed ID: 26163385
[TBL] [Abstract][Full Text] [Related]
17. Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.
Bossong MG; Antoniades M; Azis M; Samson C; Quinn B; Bonoldi I; Modinos G; Perez J; Howes OD; Stone JM; Allen P; McGuire P
JAMA Psychiatry; 2019 Feb; 76(2):199-207. PubMed ID: 30427993
[TBL] [Abstract][Full Text] [Related]
18. Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.
Soeiro-de-Souza MG; Henning A; Machado-Vieira R; Moreno RA; Pastorello BF; da Costa Leite C; Vallada H; Otaduy MC
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2221-9. PubMed ID: 26476706
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal trajectories of anterior cingulate glutamate and subclinical psychotic experiences in early adolescence: the impact of bullying victimization.
Okada N; Yahata N; Koshiyama D; Morita K; Sawada K; Kanata S; Fujikawa S; Sugimoto N; Toriyama R; Masaoka M; Koike S; Araki T; Kano Y; Endo K; Yamasaki S; Ando S; Nishida A; Hiraiwa-Hasegawa M; Edden RAE; Sawa A; Kasai K
Mol Psychiatry; 2024 Apr; 29(4):939-950. PubMed ID: 38182806
[TBL] [Abstract][Full Text] [Related]
20. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre
Egerton A; Broberg BV; Van Haren N; Merritt K; Barker GJ; Lythgoe DJ; Perez-Iglesias R; Baandrup L; Düring SW; Sendt KV; Stone JM; Rostrup E; Sommer IE; Glenthøj B; Kahn RS; Dazzan P; McGuire P
Mol Psychiatry; 2018 Nov; 23(11):2145-2155. PubMed ID: 29880882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
